Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$41.38 - $51.98 $3,351 - $4,210
-81 Reduced 1.37%
5,839 $256,000
Q1 2023

May 12, 2023

SELL
$39.69 - $49.77 $30,005 - $37,626
-756 Reduced 11.32%
5,920 $262,000
Q4 2022

Feb 13, 2023

BUY
$36.59 - $48.33 $45,005 - $59,445
1,230 Added 22.59%
6,676 $265,000
Q3 2022

Nov 14, 2022

SELL
$41.45 - $57.23 $234,192 - $323,349
-5,650 Reduced 50.92%
5,446 $251,000
Q1 2022

May 13, 2022

BUY
$44.27 - $60.77 $25,942 - $35,611
586 Added 5.58%
11,096 $599,000
Q4 2021

Feb 14, 2022

SELL
$55.0 - $72.93 $5,500 - $7,293
-100 Reduced 0.94%
10,510 $630,000
Q3 2021

Nov 15, 2021

SELL
$57.95 - $71.52 $7,533 - $9,297
-130 Reduced 1.21%
10,610 $695,000
Q2 2021

Aug 13, 2021

BUY
$48.41 - $67.51 $8,713 - $12,151
180 Added 1.7%
10,740 $679,000
Q1 2021

May 14, 2021

BUY
$39.68 - $56.52 $2,737 - $3,899
69 Added 0.66%
10,560 $515,000
Q4 2020

Feb 12, 2021

BUY
$41.02 - $51.59 $173,924 - $218,741
4,240 Added 67.83%
10,491 $433,000
Q2 2020

Aug 14, 2020

SELL
$36.07 - $50.2 $8,223 - $11,445
-228 Reduced 3.52%
6,251 $273,000
Q1 2020

May 14, 2020

BUY
$33.64 - $49.04 $5,987 - $8,729
178 Added 2.82%
6,479 $258,000
Q4 2019

Feb 13, 2020

SELL
$33.24 - $46.99 $51,488 - $72,787
-1,549 Reduced 19.73%
6,301 $296,000
Q2 2019

Aug 14, 2019

SELL
$36.4 - $45.67 $18,855 - $23,657
-518 Reduced 6.19%
7,850 $308,000
Q1 2019

May 14, 2019

BUY
$31.71 - $46.85 $21,182 - $31,295
668 Added 8.68%
8,368 $371,000
Q3 2018

Nov 13, 2018

BUY
$26.5 - $36.64 $204,050 - $282,128
7,700 New
7,700 $283,000
Q2 2018

Aug 14, 2018

SELL
$14.53 - $28.15 $188,628 - $365,443
-12,982 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$14.9 - $21.73 $193,431 - $282,098
12,982 New
12,982 $196,000

Others Institutions Holding KIDS

About ORTHOPEDIATRICS CORP


  • Ticker KIDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,894,400
  • Market Cap $514M
  • Description
  • OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; a...
More about KIDS
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.